BACKGROUND: Despite reports demonstrating feasibility of immediate dental implant placement in mandibular reconstruction with free fibula flaps for benign disease, this practice is not routinely used in the oncologic setting. The authors aim to demonstrate the safety of immediate dental implant placement for oncologic mandible reconstruction. METHODS: In 2017, the authors' center began immediate dental implant placement in free fibula flaps for oncologic patients undergoing mandibulectomy reconstruction. Immediate dental implant placement patients were compared to a historical cohort also reconstructed with computer-aided design and manufacturing technology beginning in 2011 (n = 34) as a noninferiority study design. Primary outcomes of interest included 90-day complications, time to radiotherapy, and time to and number of patients achieving dental restoration. RESULTS: Sixty-one patients underwent free fibula flaps following mandibulectomy using computer-aided design and manufacturing. Seventy-two dental implants were placed in the immediate dental implant placement cohort (n = 27). No differences were noted in major or minor 90-day complications between groups (p > 0.05). Radiotherapy was required in 55 percent in the immediate dental implant placement cohort versus 62 percent in the historical cohort, with no significant difference in time to radiotherapy (67.6 days versus 62.2 days, respectively). One dental implant was removed for nonosseointegration noted during vestibuloplasty. Fourteen (51.8 percent) immediate dental implant patients had complete dental restoration at 90 days compared with none in the historical cohort (p < 0.05). CONCLUSIONS: Immediate dental implant placement is a safe procedure with an unchanged short-term complication profile and no delay in radiotherapy initiation. Patients undergoing immediate dental implant placement are more likely to complete full dental rehabilitation. Long-term and health-related quality-of-life outcomes remain to be determined. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
BACKGROUND: Despite reports demonstrating feasibility of immediate dental implant placement in mandibular reconstruction with free fibula flaps for benign disease, this practice is not routinely used in the oncologic setting. The authors aim to demonstrate the safety of immediate dental implant placement for oncologic mandible reconstruction. METHODS: In 2017, the authors' center began immediate dental implant placement in free fibula flaps for oncologic patients undergoing mandibulectomy reconstruction. Immediate dental implant placement patients were compared to a historical cohort also reconstructed with computer-aided design and manufacturing technology beginning in 2011 (n = 34) as a noninferiority study design. Primary outcomes of interest included 90-day complications, time to radiotherapy, and time to and number of patients achieving dental restoration. RESULTS: Sixty-one patients underwent free fibula flaps following mandibulectomy using computer-aided design and manufacturing. Seventy-two dental implants were placed in the immediate dental implant placement cohort (n = 27). No differences were noted in major or minor 90-day complications between groups (p > 0.05). Radiotherapy was required in 55 percent in the immediate dental implant placement cohort versus 62 percent in the historical cohort, with no significant difference in time to radiotherapy (67.6 days versus 62.2 days, respectively). One dental implant was removed for nonosseointegration noted during vestibuloplasty. Fourteen (51.8 percent) immediate dental implant patients had complete dental restoration at 90 days compared with none in the historical cohort (p < 0.05). CONCLUSIONS: Immediate dental implant placement is a safe procedure with an unchanged short-term complication profile and no delay in radiotherapy initiation. Patients undergoing immediate dental implant placement are more likely to complete full dental rehabilitation. Long-term and health-related quality-of-life outcomes remain to be determined. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, III.
Authors: Jennifer R Cracchiolo; Anne F Klassen; Danny A Young-Afat; Claudia R Albornoz; Stefan J Cano; Snehal G Patel; Andrea L Pusic; Evan Matros Journal: Cancer Date: 2018-11-30 Impact factor: 6.860
Authors: Wess A Cohen; Claudia R Albornoz; Peter G Cordeiro; Jennifer Cracchiolo; Elizabeth Encarnacion; Meghan Lee; Michele Cavalli; Snehal Patel; Andrea L Pusic; Evan Matros Journal: Plast Reconstr Surg Date: 2016-12 Impact factor: 4.730
Authors: P J Schoen; G M Raghoebar; J Bouma; H Reintsema; F R Burlage; J L N Roodenburg; A Vissink Journal: Int J Oral Maxillofac Surg Date: 2007-09-04 Impact factor: 2.789
Authors: Jeffrey Ganeles; Axel Zöllner; Jochen Jackowski; Christiaan ten Bruggenkate; Jay Beagle; Fernando Guerra Journal: Clin Oral Implants Res Date: 2008-11 Impact factor: 5.977
Authors: Thomas W Oates; Pilar Valderrama; Mark Bischof; Rabah Nedir; Archie Jones; James Simpson; Helge Toutenburg; David L Cochran Journal: Int J Oral Maxillofac Implants Date: 2007 Sep-Oct Impact factor: 2.804
Authors: María L Sandoval; Evan B Rosen; Allen J Robert; Jonas A Nelson; Evan Matros; Daphna Y Gelblum Journal: Clin Implant Dent Relat Res Date: 2019-11-28 Impact factor: 4.259
Authors: Rachel A Anolik; Jonas A Nelson; Evan B Rosen; Joseph Disa; Evan Matros; Robert J Allen Journal: Plast Reconstr Surg Glob Open Date: 2021-09-17